The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lung cancer MDT quality assessment: A nationwide study.
 
Janna Berg
Consulting or Advisory Role - Janssen-Cilag; MSD; Pfizer; Takeda
Research Funding - AstraZeneca
 
Christina Aamelfot
No Relationships to Disclose
 
Siv-Gyda Aanes
No Relationships to Disclose
 
Marit Wilskow
No Relationships to Disclose
 
Maria Moksnes Bjaanæs
Speakers' Bureau - Bristol-Myers Squibb/Roche
 
Odd Terje Brustugun
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst)
Consulting or Advisory Role - Bayer Health (Inst); MSD Oncology (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Sverre Fluge
No Relationships to Disclose
 
Per Andersen Flåtten
No Relationships to Disclose
 
Bjorn Henning Gronberg
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
Honoraria - AstraZeneca; BMS Norway; Gilead Sciences; Janssen; Lilly; MSD; Pfizer
Consulting or Advisory Role - BMS Norway; Janssen; MSD; Pfizer
Research Funding - AstraZeneca; Roche
 
Terje Skraastad
No Relationships to Disclose
 
Rene P van Helvoirt
No Relationships to Disclose
 
Martin Petersen
No Relationships to Disclose
 
Rune Tilseth
No Relationships to Disclose
 
Torben Riis Rasmussen
No Relationships to Disclose
 
Kirill Neumann
No Relationships to Disclose